KinderPharm

  • Home
  • Our Company
    • About KinderPharm
    • Why KinderPharm?
    • Management
    • Advisory Board
    • Our Purpose
  • Services
    • Pediatric Regulatory
      • Protocol Development
      • Waivers and Deferrals
      • PIP and PSP Submission
    • Age Appropriate Formulation
      • Pediatric Formulation Development
    • Juvenile Toxicology
      • Juvenile Toxicology Study Design & Conduct
    • Pharmacometrics
      • PK Data Analysis
      • Modeling & Simulation
        • Physiologically Based Pharmacokinetic (PBPK)
        • Pediatric Extrapolation
        • Population PK (POP PK) & Sparse Sampling
    • Clinical Trials
  • Resources
    • FDA Pediatric Information
    • EMA Pediatric Information
    • Other Regions Pediatric Information
  • News & Events
    • News
    • Events
  • Contact Us
Our Office Locations:

 

KinderPharm LLC (Headquarters)
100 Arrandale Blvd., Suite 101
Exton, PA 19341
Telephone: (+1)610.458.1051


 

KinderPharm LLC (USA)
Cambridge, MA
Telephone: (+1)610.458.1051


 

KinderPharm LLC (UK)
40 Bank Street
Level 18
Canary Wharf, London E14 5NR
Telephone: (+44)2 0707 87513


 

Press and Media:

Please direct your inquiries to press@KinderPharm.com or use the Press Release RSS Feed

View our latest press releases
  • CRISPR Babies
  • FDA Unveils Guidances on Innovative Trial Design
  • Synteract Acquires Pediatric CRO KinderPharm to Further Strengthen its Pediatric Center of Development
  • Assessing Drug Safety in Children — The Role of Real-World Data
  • AAPS Conference Highlights Modeling & Simulation
Investors:

For investors relations please contact Lynda Graham at lgraham@kinderpharm.com

Contact Form

Please use the form provided below to send us a message

Name (required)

Email (required)

Phone Number

Where Did You Hear About Us?

Subject

Your Message (required)

 

 

PKPD Inc logo

Search this website

Meet Us at Industry Events

Meet with us

Sign up for our Newsletter

Partner With Us For

  • Pediatric Regulatory
    • Protocol Development
    • Waivers and Deferrals
    • PIP and PSP Submission
  • Age Appropriate Formulation
    • Pediatric Formulation Development
  • Juvenile Toxicology
    • Juvenile Toxicology Study Design & Conduct
  • Pharmacometrics
    • PK Data Analysis
    • Modeling & Simulation
      • Physiologically Based Pharmacokinetic (PBPK)
      • Pediatric Extrapolation
      • Population PK (POP PK) & Sparse Sampling
  • Clinical Trials

Read Our Latest Tweets

  • New York Venture Summit - great place to meet new companies and investors. https://t.co/BpvYTwjklH July 19, 2017 11:32 pm
  • Thank you #LifeSciencesPA for hosting the #PAPavilion Looking forward to #BIO2018 in Boston. https://t.co/DMmvmSYItT June 27, 2017 12:35 am
  • Bringing Better Medicines to Children through collaborations at #BIO2017 KinderPharm CEO Dr Graham and American M… https://t.co/YLxQwVZGKw June 22, 2017 12:02 am
  • Follow Us on Twitter

Our Mission

We have a single mission, simply “Bringing Better Medicines to Children” – but as everybody involved in pediatric drug development knows, this is not simple.

Quick Links

  • Services
  • Management
  • Advisory Board
  • Contact Us
  • Careers

Our Locations

US Location
100 Arrandale Blvd. (Suite 101)
Exton, PA 19341 USA

UK Location
40 Bank Street Level 18 Canary Wharf,
London E14 5NR UK

Copyright © 2019 - KinderPharm LLC - Privacy Policy - Terms of Service - Log in